Informa
TIDES Asia: Oligonucleotide & Peptide Therapeutics
2025年2月26-28日
日本京都, Westin Miyako Kyoto

主會議 第2天

主會議 第2天

7:45am - 8:10am25分鐘
Registration and Coffee
報到・咖啡時光
    8:10am - 8:15am5分鐘
    Chairperson’s Remarks
    主席致辭
    • Yogesh Sanghvi, PhD - President, Rasayan Inc.
    8:15am - 8:45am30分鐘
    Morning Spotlight Presentation: Isolation and Drying of Peptides and 0ligonucleotides - Improved Production Capacities During Large Scale Manufacturing
    晨間焦點簡報：胜肽和寡核苷酸的分離和乾燥—提高大規模生產過程中的生產能力
    • Keith Cronce - Chief Operating Officer, Fluid Air, A Division of Spraying Systems
    Plenary Session
    主題講演單元
    8:45am - 9:15am30分鐘
    mRNA Advances Track
    mRNA的進歩分會
    Complete Chemical Synthesis of mRNA for Cancer Vaccine
    癌症疫苗 mRNA 的完整化學合成
    • Hiroshi Abe, PhD - Professor, Department of Chemistry, Graduate School, Nagoya University
    9:15am - 9:45am30分鐘
    mRNA Advances Track
    mRNA的進歩分會
    Developing the Next Generation RSV Vaccine
    下一代 RSV 疫苗的開發
    • Dong Shen, MD, PhD - CEO, RNAimmune, Inc.
    9:45am - 10:15am30分鐘
    mRNA Advances Track
    mRNA的進歩分會
    RNA Therapy for Asthma
    哮喘的 RNA 治療藥
    • Thomas Langenickel, MD, PhD - Chief Medical Officer, Ethris GmbH
    10:15am - 10:55am40分鐘
    Networking Refreshment Break with Poster and Exhibit Viewing
    互動交流休息時間，觀賞海報和展覽
    Networking Refreshment Break with Poster and Exhibit Viewing
    互動交流休息時間，觀賞海報和展覽
      10:20am - 10:35am15分鐘
      TIDES Talks in the Exhibit Hall
      TIDES講座（展覽廳）
      Initiating CMO Operations at Axolabs Berlin: From Discovery to Commercial Therapeutic Oligonucleotides
      Axolabs Berlin 的 CMO 運作說明：從發現到推出核苷酸療法
      • Thomas Rupp - Managing Director, Axolabs Berlin GmbH
      Concurrent Conference Tracks
      同時進行的各個分會
      10:55am - 11:00am5分鐘
      Oligonucleotide Track
      寡核苷酸分會
      Chairperson’s Remarks: Track 1
      主席致辭：分會1
      • Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences
      10:55am - 11:00am5分鐘
      Peptide Track
      胜肽分會
      Chairperson’s Remarks: Track 2
      主席致辭：分會2
      • El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
      11:00am - 11:30am30分鐘
      Oligonucleotide Track
      寡核苷酸分會
      CMC Strategies for the Characterization of Stereopure Platform Chemistry
      用於表徵立體純平台化學的 CMC 策略
      • Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences
      11:00am - 11:30am30分鐘
      Peptide Track
      胜肽分會
      Industry Perspective on the Selection of Regulatory Starting Materials for Synthetic Peptides
      關於如何選擇監管對象合成肽起始材料的業界見解
      • John Lopez, PhD - Associate Director Science & Technology, Novartis
      11:30am - 12:00pm30分鐘
      Oligonucleotide Track
      寡核苷酸分會
      Template-independent Enzymatic Synthesis of Natural and Fully Modified siRNA Oligonucleotides
      天然/完全修飾的 siRNA 寡核苷酸的不依賴模板的酶合成
      • Jonathan Rittichier, PhD - Chief Scientific Officer & Co-Founder, EnPlusOne BioSciences
      11:30am - 12:00pm30分鐘
      Peptide Track
      胜肽分會
      Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase
      原料藥中的雜質以及申請（美國、歐盟、巴西和中國市場）和商業化階段面臨的課題
      • Dinesh Parmar - Associate Director Regulatory Affairs, PolyPeptide Group
      12:00pm - 12:30pm30分鐘
      Oligonucleotide Track
      寡核苷酸分會
      Empowering Oligonucleotide Therapeutics: From Raw Materials to Manufacturing, and Advanced Delivery Solutions
      強化寡核苷酸治療藥：從原料到製造以及先進的給藥解決方案
      • Sirat Sikka - Senior Scientist, Applications and Innovation, Thermo Fisher Scientific
      12:00pm - 12:30pm30分鐘
      Peptide Track
      胜肽分會
      Statistical Design of Experiments in Peptide Process Development
      胜肽製程開發中實驗的統計設計
      • Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
      12:30pm - 1:40pm70分鐘
      Networking Luncheon with Poster and Exhibit Viewing
      交流時間・午餐會，觀賞海報和展覽
        1:40pm - 1:45pm5分鐘
        Oligonucleotide Track
        寡核苷酸分會
        Chairperson’s Remarks: Track 1
        主席致辭：分會1
        • Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences
        1:40pm - 1:45pm5分鐘
        Peptide Track
        胜肽分會
        Chairperson’s Remarks: Track 2
        主席致辭：分會2
        • El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
        1:45pm - 2:15pm30分鐘
        Oligonucleotide Track
        寡核苷酸分會
        Drug Substance and Drug Product CMC Strategies for Start-Ups and Smaller Companies
        新創公司和小型公司的原料藥和藥品 CMC 策略
        • Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
        1:45pm - 2:15pm30分鐘
        Peptide Track
        胜肽分會
        Development of an Efficient and Scalable CSPS Process for a Mid-Sized Cyclic Peptide
        開發適用於中型環肽的高效且可擴大縮小的 CSPS 製程
        • Hiroshi Iwamura, PhD - Deputy Head of API Process Development Department, Chugai Pharmaceutical Co., Ltd.
        2:15pm - 2:45pm30分鐘
        Oligonucleotide Track
        寡核苷酸分會
        NMA Manufacturing Process Development
        NMA生產製程開發
        • Carter Cooperman - Research Associate II, Ionis
        2:15pm - 2:45pm30分鐘
        Peptide Track
        胜肽分會
        Overcoming Aggregation Challenges in Peptide Manufacturing: Technical Approach and Case Studies
        克服胜肽生產過程中的聚集問題：技術方法與案例研究
        • El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
        2:45pm - 3:15pm30分鐘
        Oligonucleotide Track
        寡核苷酸分會
        Advancements in Oligonucleotide Sequencing Capabilities
        寡核苷酸定序能力的進步
        • Collin Wetzel - Associate Principal Scientist, Analytical Development, Nitto Avecia
        2:45pm - 3:15pm30分鐘
        Peptide Track
        胜肽分會
        An Inline Monitoring Method Integrated Flow Chemistry for Peptide Synthesis and Manufacturing
        用於胜肽合成和製造的整合流動化學線上監測方法
        • Pengyu Xu, PhD - President and Representative Director, SynCrest Inc.
        3:15pm - 3:45pm30分鐘
        Networking Refreshment Break with Poster and Exhibit Viewing
        互動交流休息時間，觀賞海報和展覽
          3:45pm - 4:15pm30分鐘
          Oligonucleotide Track
          寡核苷酸分會
          Development of a Kilogram-Scale Manufacturing Route for Guadecitabine: A Dinucleotide DNA Methyltransferase Inhibitor
          Guadecitabine公斤級生產方法的開發：一種二核苷酸 DNA 甲基轉移酶抑製劑
          • Yogesh Sanghvi, PhD - President, Rasayan Inc.
          3:45pm - 4:15pm30分鐘
          Peptide Track
          胜肽分會
          Improving Robustness and Recovery in a GLP-1 Purification Process
          提高 GLP-1 純化過程中的穩定性和回收率
          • Yvan Ruland, PhD - Technology Consultant Chromatography, Sartorius Stedim Singapore
          4:15pm - 4:45pm30分鐘
          Oligonucleotide Track
          寡核苷酸分會
          Pioneering the Development of Highly Stable Site-Specific Antibody-Oligonucleotide Conjugates (AOC) Using Fc-Targeting Reagents
          率先利用 Fc 標靶試劑開發高穩定性的位點特異性抗體寡核苷酸結合物 (AOC)
          • Tsubasa Aoki, PhD - Researcher, Ajinomoto Co.
          4:15pm - 4:45pm30分鐘
          Peptide Track
          胜肽分會
          Liquid-phase Peptide Fragment Manufacturing Technologies and Workflows
          液相肽片段的生產技術和工作流程
          • Adrian Amador, PhD - Director of Process Chemistry, Cambrex
          4:45pm - 5:15pm30分鐘
          Oligonucleotide Track
          寡核苷酸分會
          Oligonucleotide Purification and CMC Strategies - Increasing Efficiencies/Overcoming Challenges
          寡核苷酸純化和 CMC 策略：提高效率並克服課題
          • Robert Gronke, PhD - Senior Principal Scientist, Technical Development, Biogen, Inc
          4:45pm - 5:15pm30分鐘
          Peptide Track
          胜肽分會
          A Breakthrough for “TIDEs” Researchers in CMC: Developing a State-of-the-Art Technology to Improve Upon Traditional Labor-Intensive Methods of Purification
          對「TIDEs」研究人員而言的 CMC 上的突破：CMC 中“TIDEs”研究人員的突破：開發可改變傳統勞動密集型純化方法的尖端替代方案
          • Katsuhiko Miwa - CEO, ChromaJean
          5:15pm - 6:15pm60分鐘
          Networking Cocktail Reception with Poster and Exhibit Viewing
          社交雞尾酒會，觀賞海報和展覽
            6:15pm - 6:20pm5分鐘
            Close of Day Two
            第2天結束
              會前研討會 (上午) & 主會議 第1天 (下午)
              Next主會議 第3天

              * 活動內容有可能不事先告知作更動及調整。